Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0677930 (primary tumor)
 20,210 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

An unusual case of a benign giant cell tumor of bone with pulmonary metastasis is reported. A 23-year-old man had a painful tumor in the right radial olecranon that proved to be a histologically benign giant cell tumor. Curettage and bone-grafting were performed, but the tumor recurred twice, 8 months and 20 months after initial treatment. Histological examination of biopsy materials from the recurring tumor showed typical benign giant cell tumors. Five years later, wedge resections were performed for bilateral pulmonary nodules, which had been detected by chance. The pulmonary nodules turned out to be histologically similar to the primary tumor of the olecranon. Almost 7 years later, he was asymptomatic and the chest radiograph was clear, and there was no local recurrence of the lesion.
 ...
PMID:[Multiple pulmonary metastasis from histologically benign giant cell tumor of the right radial olecranon]. 175 25

Pulmonary metastasis of benign giant cell tumor of bone is very rare, and its biological behavior is difficult to predict. In the present study, we analyzed the clinical characteristics of and related risk factors for pulmonary metastasis of this tumor. Forty-six patients with lung metastasis were analyzed. In total, 60.9% of the primary tumors were located around the knee joint. The Campanacci stage of all tumors was stage 3. Surgery of the primary tumor included curettage in 37 patients, resection in 8, and amputation in 1. Local recurrence after the primary surgery occurred in 34 patients. The recurrence rate, Campanacci stage, and surgical method were significant risk factors for lung metastasis. The median postoperative metastasis time in the lower limbs, upper limbs, and axial skeleton was 20.1, 7.9, and 1.4 months, respectively (p=0.010). The median metastasis time in patients with and without recurrence was 13.7 and 43.2 months, respectively (p=0.018). Eighteen patients had unilateral metastasis and 28 had bilateral metastasis. Most lesions (n=38) were located in the peripheral lung. Nineteen patients received treatment, and 12 of them underwent tumor resection. The 5-year overall survival rate was 94.4%. This study showed that local recurrence, a high Campanacci stage, and curettage were possible high-risk factors for pulmonary metastasis. The primary lesion site and local recurrence may be related to the metastasis time. The survival rate of patients with pulmonary metastasis was high.
 ...
PMID:Clinical characteristics and risk factors analysis of lung metastasis of benign giant cell tumor of bone. 2844 31